The historical data trend for Ebos Group's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Ebos Group's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ebos Group's EV-to-EBIT Distribution in the Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Ebos Group's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Ebos Group's EV-to-EBIT falls into.
Ebos Group EV-to-EBIT Calculation
Ebos Group's EV-to-EBIT for today is calculated as:
Ebos Group's current Enterprise Value is NZ$8,489 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Ebos Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was NZ$490 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ebos Group (NZSE:EBO) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Ebos Group's Enterprise Value for the quarter that ended in Dec. 2023 was NZ$8,359 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Ebos Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was NZ$490 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ebos Group EV-to-EBIT Related Terms
Thank you for viewing the detailed overview of Ebos Group's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.
Ebos is the largest pharmaceutical wholesaler and distributor across Australia and New Zealand. It services community pharmacies and hospitals, which contribute around 60% and 30% of revenue respectively. Drug pricing and wholesale margins for PBS medicine are governed by the Australian government's Pharmaceutical Benefits Scheme, or PBS. Wholesale gross margins are capped at 7% for community pharmacy and 10% for hospitals, and ongoing price reform typically results in low single digit revenue growth. Aside from pharma distribution, Ebos operates an animal health product wholesale, manufacturing and retail business, as well as undertaking third party logistics services. These segments are smaller contributors to group revenue but due to the unregulated nature are higher-margin operations.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
NZSE:EBO has been successfully added to your 